Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests.
Researchers found these medications show promise in lowering the risk of cognitive impairment.
Obesity and diabetes drugs, particularly semaglutides like Wegovy and Ozempic, may reduce a person’s risk of dementia, a new study suggests.
Researchers found these medications show promise in lowering the risk of cognitive impairment.